🇮🇱 Vyzulta in Israel

Vyzulta (LATANOPROSTENE BUNOD) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Vyzulta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Israel

Frequently asked questions

Is Vyzulta approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Vyzulta in Israel?

Bausch Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.